RT Journal Article
SR Electronic
T1 Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.04.21264513
DO 10.1101/2021.10.04.21264513
A1 Elizabeth M. Garry
A1 Andrew R. Weckstein
A1 Kenneth Quinto
A1 Tamar Lasky
A1 Aloka Chakravarty
A1 Sandy Leonard
A1 Sarah E. Vititoe
A1 Imaani J. Easthausen
A1 Jeremy A. Rassen
A1 Nicolle M. Gatto
YR 2021
UL http://medrxiv.org/content/early/2021/10/05/2021.10.04.21264513.abstract
AB Importance Algorithms for classification of inpatient COVID-19 severity are necessary for confounding control in studies using real-world data (RWD).Objective To explore use of electronic health record (EHR) data to inform an administrative data algorithm for classification of supplemental oxygen or noninvasive ventilation (O2/NIV) and invasive mechanical ventilation (IMV) to assess disease severity in hospitalized COVID-19 patients.Design In this retrospective cohort study, we developed an initial procedure-based algorithm to identify O2/NIV, IMV, and NEITHER O2/NIV nor IMV in two inpatient RWD sources. We then expanded the algorithm to explore the impact of adding diagnoses indicative of clinical need for O2/NIV (hypoxia, hypoxemia) or IMV (acute respiratory distress syndrome) and O2-related patient vitals available in the EHR. Observed changes in severity categorization were used to augment the administrative algorithm.Setting Optum de-identified COVID-19 EHR data and HealthVerity claims and chargemaster data (March – August 2020).Participants Among patients hospitalized with COVID-19 in each RWD source, our motivating example selected dexamethasone (DEX+) initiators and a random selection of patients who were non-initiators of a corticosteroid of interest (CSI-) matched on date of DEX initiation, age, sex, baseline comorbidity score, days since admission, and COVID-19 severity level (NEITHER, O2/NIV, IMV) on treatment index.Main Outcome and Measures Inpatient COVID-19 severity was defined using the algorithms developed to classify respiratory support requirements among hospitalized COVID-19 patients (NEITHER, O2/NIV, IMV). Measures were reported as the treatment-specific distributions of patients in each severity level, and as observed changes in severity categorization between the initial procedure-based and expanded algorithms.Results In the administrative data cohort with 5,524 DEX+ and CSI- patient pairs matched using the initial procedure-based algorithm, 30% were categorized as O2/NIV, 5% as IMV, and 65% as NEITHER. Among patients assigned NEITHER via the initial algorithm, use of an expanded algorithm informed by the EHR-based algorithm shifted 54% DEX+ and 28% CSI- to O2/NIV, and 2% DEX+ and 1% CSI- to IMV. Among patients initially assigned O2/NIV, 7% DEX+ and 3% CSI- shifted to IMV.Conclusions and Relevance Application of learnings from an EHR-based exploration to our administrative algorithm minimized treatment-differential misclassification of COVID-19 severity.Competing Interest StatementThis paper is part of a research collaboration agreement between the U.S. Food and Drug Administration (FDA) and Aetion, Inc. to use real-world data to advance the understanding and the natural history of coronavirus disease (COVID-19) in specific patient populations, as well as treatment and diagnostic patterns during the COVID-19 pandemic. This paper reflects the views of the authors and should not be construed to represent FDA's views or policies. EMG, ARW, SEV, IJE, JAR, and NMG are employees of Aetion, Inc., with stock options or existing equity.Funding StatementThis paper is part of a research collaboration agreement between the U.S. Food and Drug Administration (FDA) and Aetion, Inc. to use real-world data to advance the understanding and the natural history of coronavirus disease (COVID-19) in specific patient populations, as well as treatment and diagnostic patterns during the COVID-19 pandemic.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the New England institutional review board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPatient-level data belong to third parties and cannot be shared publicly. Upon reasonable request, researchers may obtain limited access to data and analytics infrastructure.COVID-19coronavirus disease 19CPTcurrent procedural terminologyCSIcorticosteroid of interest (DEX, methylprednisolone, prednisone, hydrocortisone)CSI-random selection of patients who had not (yet) initiated any CSIDEXdexamethasoneDEX+dexamethasone initiators in the matched cohortECMOextracorporeal membrane oxygenationEHRelectronic health recordFDAUnited States Food and Drug AdministrationHCPCShealthcare common procedure coding systemICD-10-CMinternational classification of disease codes, 10th revision, clinical modificationICD-10-PCSinternational classification of disease codes, 10th revision, procedural classification systemIMVinvasive mechanical ventilationmWHOmodified version of WHO Clinical Progression Scale for COVID-19 severityNEITHERneither O2/NIV nor IMVNIVnoninvasive ventilationO2oxygen/supplemental oxygenPaO2/FIO2ratio of arterial oxygen partial pressure to fractional inspired oxygenRWDreal-world dataSpO2blood oxygen saturationUSUnited StatesWHOWorld Health Organization